A Panel of Plasma Biomarkers for Differential Diagnosis of Parkinsonian Syndromes

OBJECTIVE: The aim of our study is to explore the most reliable panel of plasma biomarkers for differential diagnosis of parkinsonian syndromes (PDSs). We selected five kinds of neurodegenerative proteins in plasma: neurofilament light chain (NfL), α-synuclein (α-syn), total tau, β-amyloid 42 (Aβ42)...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qi, Li, Zhen, Han, Xiaoxuan, Shen, Xiao, Wang, Fei, Bai, Lipeng, Li, Zhuo, Zhang, Rui, Wang, Yanlin, Zhu, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891509/
https://www.ncbi.nlm.nih.gov/pubmed/35250451
http://dx.doi.org/10.3389/fnins.2022.805953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891509/
https://www.ncbi.nlm.nih.gov/pubmed/35250451
http://dx.doi.org/10.3389/fnins.2022.805953

Ejemplares similares